Frontlight ResearchEarly access
Trial site
Northwest Cancer Specialists, P.C.
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Bladder cancer2 trials
- Colorectal cancer2 trials
- Cervical cancer1 trial
- Endometrial cancer1 trial
- Liver and biliary tract cancer1 trial
- Phase
- Phase 35 trials
- Phase 1/22 trials
- Phase 22 trials
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Terminated1 trial
- Lead sponsor
- Pfizer3 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- G1 Therapeutics, Inc.1 trial
- Genprex, Inc.1 trial
- Hoffmann-La Roche1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Endometrial cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026